Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Operating Income (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) reported Operating Income of $132.69 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 33.9% from $200.78 million a year earlier but up 232.0% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Operating Income (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Dr Reddys Laboratories' Operating Income came in at $347.04 million, down 58.2% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $539 million, down 36.0% from FY2025.

  • Operating Income has a five-year compound annual growth rate of 10.2% (FY2021 to FY2026).
  • By fiscal year, Operating Income came in at $842 million in FY2025 (+3.6%), $813 million in FY2024 (+17.0%), $695 million in FY2023 (+78.7%) and $389 million in FY2022 (+17.2%).
  • Five-year quarterly Operating Income spans a low of $14.49 million in fiscal Q4 2026 and a high of $221.71 million in fiscal Q3 2025.
  • Year over year, Operating Income has now declined in each of the last six quarters, with an average decline of 28.0% over the last eight quarters.
  • The high point for year-over-year Operating Income in five years was fiscal Q4 2023 (growth of 949.4%); the low point was fiscal Q4 2026 (a decline of 92.9%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $39.97 million (Q1 2027), $14.49 million (Q4 2026) and $159.89 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 12.79 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 6.18 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 6.27 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 5.59 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 4.39 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 3.46 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 5.47 Bn
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn 132.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 132.69 Mn
Jun 30, 2026 39.97 Mn
Mar 31, 2026 14.49 Mn
Dec 31, 2025 159.89 Mn
Sep 30, 2025 200.78 Mn
Jun 30, 2025 204.19 Mn
Mar 31, 2025 203.79 Mn
Dec 31, 2024 221.71 Mn
Sep 30, 2024 209.55 Mn
Jun 30, 2024 214.88 Mn
Mar 31, 2024 180.13 Mn
Dec 31, 2023 207.37 Mn
Sep 30, 2023 216.14 Mn
Jun 30, 2023 215.00 Mn
Mar 31, 2023 212.00 Mn
Dec 31, 2022 151.00 Mn
Sep 30, 2022 200.00 Mn
Jun 30, 2022 195.00 Mn
Mar 31, 2022 20.20 Mn
Dec 31, 2021 75.00 Mn
API Access

Dr Reddys Laboratories Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=RDY&period=max&api_key=YOUR_API_KEY